AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
Prognostic factors of combined viral load and CD4(+) cell count responses under triple antiretroviral therapy, aquitaine cohort, 1996-1998
Authors: Marimoutou, C Chene, G Mercie, P Neau, D Farbos, S Morlat, P Ceccaldi, J Dabis, F
Citation: C. Marimoutou et al., Prognostic factors of combined viral load and CD4(+) cell count responses under triple antiretroviral therapy, aquitaine cohort, 1996-1998, J ACQ IMM D, 27(2), 2001, pp. 161-167
Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy
Authors: Saves, M Morlat, P Chene, G Peuchant, E Pellegrin, I Bonnet, F Bernard, N Lacoste, D Salamon, R Beylot, J
Citation: M. Saves et al., Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy, CLIN IMMUNO, 99(3), 2001, pp. 347-352
Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus
Authors: Leport, C Franck, J Chene, G Derouin, F Ecobichon, JL Pueyo, S Miro, JM Luft, BJ Morlat, P Dumon, H
Citation: C. Leport et al., Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus, CL DIAG LAB, 8(3), 2001, pp. 579-584
Prognostic score of short-term survival in HIV-infected patients admitted to medical intensive care units
Authors: Bonarek, M Morlat, P Chene, G Rapin, D Hilbert, G Pillet, O Gabinski, C
Citation: M. Bonarek et al., Prognostic score of short-term survival in HIV-infected patients admitted to medical intensive care units, INT J STD A, 12(4), 2001, pp. 239-244
The absence of hyperbilirubinaemia is highly predictive of treatment failure in advanced HIV-infected patients treated with indinavir
Authors: Nouts, C Bonarek, M Morlat, P Delevaux, I Bonnet, F Lacoste, D Bernard, N Beylot, J
Citation: C. Nouts et al., The absence of hyperbilirubinaemia is highly predictive of treatment failure in advanced HIV-infected patients treated with indinavir, INT J STD A, 12(1), 2001, pp. 29-33
Clinical prediction of lower limb deep vein thrombosis in symptomatic hospitalized patients
Authors: Constans, J Nelzy, ML Salmi, LR Skopinski, S Saby, JC Le Metayer, P Morlat, P Conri, C
Citation: J. Constans et al., Clinical prediction of lower limb deep vein thrombosis in symptomatic hospitalized patients, THROMB HAEM, 86(4), 2001, pp. 985-990
Increase of lipid plasma concentrations under protease inhibitor-containing regimens are not related to modifications of the tumour necrosis factor system
Authors: Bonnet, F Saves, M Droz, C Peuchant, E Chene, G Beylot, J Morlat, P
Citation: F. Bonnet et al., Increase of lipid plasma concentrations under protease inhibitor-containing regimens are not related to modifications of the tumour necrosis factor system, AIDS, 15(7), 2001, pp. 940-941
Bleeding events of low molecular weight heparins: 15 cases
Authors: Bonnet, F Morlat, P de Witte, S Bernard, N Lacoste, D Beylot, J
Citation: F. Bonnet et al., Bleeding events of low molecular weight heparins: 15 cases, REV MED IN, 22(8), 2001, pp. 761-763
Sarcoidosis and associated illnesses. A 32-case retrospective study
Authors: Bonnet, F Dubuc, J Morlat, P Delbrel, X Doutre, MS de Witte, S Bernard, N Lacoste, D Longy-Boursier, M Beylot, J
Citation: F. Bonnet et al., Sarcoidosis and associated illnesses. A 32-case retrospective study, REV MED IN, 22(7), 2001, pp. 619-623
Clinical and laboratory findings of cytomegalovirus infection in 115 hospitalized non-immunocompromised adults
Authors: Bonnet, F Neau, D Viallard, JF Morlat, P Ragnaud, JM Dupon, M Legendre, P Imbert, Y Lifermann, F Le Bras, M Beylot, J Longy-Boursier, M
Citation: F. Bonnet et al., Clinical and laboratory findings of cytomegalovirus infection in 115 hospitalized non-immunocompromised adults, ANN MED IN, 152(4), 2001, pp. 227-235
Increase of atherogenic plasma profile in HIV-infected patients treated with protease inhibitor-containing regimens
Authors: Bonnet, F Saves, M Droz, C Peuchant, E Chene, G Beylot, J Morlat, P
Citation: F. Bonnet et al., Increase of atherogenic plasma profile in HIV-infected patients treated with protease inhibitor-containing regimens, J ACQ IMM D, 25(2), 2000, pp. 199-200
Dual nucleoside regimens in nonadvanced HIV infection: Prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998
Authors: Morlat, P Marimoutou, C Dequae-Merchadou, L Pellegrin, I Mercie, I Neau, D Beylot, J Dabis, F
Citation: P. Morlat et al., Dual nucleoside regimens in nonadvanced HIV infection: Prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998, J ACQ IMM D, 23(3), 2000, pp. 255-260
A possible association between Chlamydiae psittacci infection and temporalarteritis
Authors: Bonnet, F Morlat, P Delevaux, I Gavinet, AM Parrens, M Bernard, N Lacoste, D Beylot, J
Citation: F. Bonnet et al., A possible association between Chlamydiae psittacci infection and temporalarteritis, JOINT BONE, 67(6), 2000, pp. 550-552
Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine cohort, France, 1999
Authors: Thiebaut, R Daucourt, V Mercie, P Ekouevi, KD Malvy, D Morlat, P Dupon, M Neau, D Farbos, S Marimoutou, C Dabis, F
Citation: R. Thiebaut et al., Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine cohort, France, 1999, CLIN INF D, 31(6), 2000, pp. 1482-1487
Intrafamilial transmission of hepatitis C virus in human immunodeficiency virus and hepatitis C virus co-infected patients
Authors: Huet, C Dabis, F Saillour, F Trimoulet, P Morlat, P Rispal, P Dupon, M de la Taille, C Partisani, M Bertrand, M Ragnaud, JM Couzigou, P
Citation: C. Huet et al., Intrafamilial transmission of hepatitis C virus in human immunodeficiency virus and hepatitis C virus co-infected patients, GASTRO CL B, 24(6-7), 2000, pp. 611-617
Factors associated with medical management of HIV-infected persons in two French districts, 1993-1995
Authors: Schwoebel, V Delmas, MC Michon, C Hubert, JB Couturier, E Morlat, P Boue, F Simonpoli, AM Dabis, F Brune, JB
Citation: V. Schwoebel et al., Factors associated with medical management of HIV-infected persons in two French districts, 1993-1995, REV EPIDEM, 48(1), 2000, pp. 7-15
Upper extremity deep venous thrombosis: 40 hospitalized patients.
Authors: Massoure, PL Constans, J Caudry, M Morlat, P Skopinski, S Beylot, J Longy-Boursier, M Le Bras, M Combe, C Quinton, A Saric, J Conri, C
Citation: Pl. Massoure et al., Upper extremity deep venous thrombosis: 40 hospitalized patients., J MAL VASC, 25(4), 2000, pp. 250-255
Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment
Authors: Thiebaut, R Morlat, P Jacqmin-Gadda, H Neau, D Mercie, P Dabis, F Chene, G
Citation: R. Thiebaut et al., Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment, AIDS, 14(8), 2000, pp. 971-978
Hematological and immunological signs of CMV infection in hospitalized non-immunocompromised adult.
Authors: Bonnet, F Morlat, P Neau, D Viallard, JF Ragnaud, JM Dupon, M Legendre, P Imbert, Y Lifermann, F Le Bras, M Beylot, J Longy-Boursier, M
Citation: F. Bonnet et al., Hematological and immunological signs of CMV infection in hospitalized non-immunocompromised adult., REV MED IN, 21(7), 2000, pp. 586-594
Multiple medullary and extramedullary plasmocytoma in an HIV-infected female patient.
Authors: Delevaux, I Bernard, N Ramanampamonjy, R Morlat, P Lacoste, D Bonnet, F Bonnel, C Deminiere, C Beylot, J
Citation: I. Delevaux et al., Multiple medullary and extramedullary plasmocytoma in an HIV-infected female patient., REV MED IN, 21(7), 2000, pp. 623-627
Clinico-biological study in 100 symptomatic patients with factor V Leiden mutation
Authors: Vatan, R Delpeu, K Vergnes, C Constans, J Le Bougeant, P Nurden, P Roudaut, MF Boisseau, M Le Metayer, P Morlat, P Longy-Boursier, M Le Bras, M Beylot, J Midy, D Baste, JC Conri, C
Citation: R. Vatan et al., Clinico-biological study in 100 symptomatic patients with factor V Leiden mutation, REV MED IN, 21(5), 2000, pp. 465
Pneumopericardium without pneumomediastinum
Authors: Delevaux, I Bernard, N Lacoste, D Nouts, C Morlat, P Beylot, J
Citation: I. Delevaux et al., Pneumopericardium without pneumomediastinum, REV MED IN, 21(3), 2000, pp. 297-298
Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients
Authors: Saves, M Raffi, F Clevenbergh, P Marchou, B Waldner-Combernoux, A Morlat, P Le Moing, V Riviere, C Chene, G Leport, C
Citation: M. Saves et al., Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients, ANTIM AG CH, 44(12), 2000, pp. 3451-3455
Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients
Authors: Molina, JM Ferchal, F Rancinan, C Raffi, F Rozenbaum, W Sereni, D Morlat, P Journot, V Decazes, JM Chene, G
Citation: Jm. Molina et al., Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients, J INFEC DIS, 182(2), 2000, pp. 599-602
Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus - Aquitaine Cohort, France, 1986-1997
Authors: Thiessard, F Morlat, P Marimoutou, C Labouyrie, E Ragnaud, JM Pellegrin, JL Dupon, M Dabis, F
Citation: F. Thiessard et al., Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus - Aquitaine Cohort, France, 1986-1997, CANCER, 88(7), 2000, pp. 1696-1702
Risultati: 1-25 | 26-31